|
Status |
Public on Sep 01, 2024 |
Title |
Doxorubicin and protective inhibitor treated iPSC derived cardiomyocytes |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by high throughput sequencing
|
Summary |
Investigation of drug and gene rescues doxorubicin induced alterations of transcriptomic and metabolic profiles
|
|
|
Overall design |
RNA-seq analysis on 1) WT and CA12 KO iCMs treated with vehicle or doxorubicin (0.5 µM) and 2) WT iCMs treated with doxorubicin plus indisulam to gain a comprehensive understanding of their genome-wide transcriptomic changes.
|
|
|
Contributor(s) |
Liu C, Shen M |
Citation missing |
Has this study been published? Please login to update or notify GEO. |
|
Submission date |
Sep 14, 2022 |
Last update date |
Sep 01, 2024 |
Contact name |
Chun Liu |
E-mail(s) |
liuchun@stanford.edu
|
Organization name |
stanford
|
Street address |
1291 Welch Road BMI building, 3200-CVI Rm
|
City |
palo alto |
State/province |
CA |
ZIP/Postal code |
94304 |
Country |
USA |
|
|
Platforms (1) |
GPL20301 |
Illumina HiSeq 4000 (Homo sapiens) |
|
Samples (10)
|
GSM6578662 |
Wildtype (WT) iCMs treated with DMSO 1 |
GSM6578663 |
Wildtype (WT) iCMs treated with DMSO 2 |
GSM6578664 |
Wildtype (WT) iCMs treated with doxorubicin 1 |
GSM6578665 |
Wildtype (WT) iCMs treated with doxorubicin 2 |
GSM6578666 |
Wildtype (WT) iCMs treated with doxorubicin and indisulam 1 |
GSM6578667 |
Wildtype (WT) iCMs treated with doxorubicin and indisulam 2 |
GSM6578668 |
CA12 knockout (KO) iCMs treated with DMSO 1 |
GSM6578669 |
CA12 knockout (KO) iCMs treated with DMSO 2 |
GSM6578670 |
CA12 knockout (KO) iCMs treated with doxorubicin 1 |
GSM6578671 |
CA12 knockout (KO) iCMs treated with doxorubicin 2 |
|
Relations |
BioProject |
PRJNA880508 |